![]() |
市場調査レポート
商品コード
1439262
心電図(ECG)モニタリング機器 - 世界市場の考察、競合情勢、市場予測(2030年)ECG Monitoring Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
心電図(ECG)モニタリング機器 - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の心電図(ECG)モニタリング機器の市場規模は、2021年に44億4,000万米ドル、2030年までに62億米ドルに達し、2024年~2030年の予測期間にCAGRで5.74%の成長が見込まれます。心電図(ECG)モニタリング機器の需要は、主に心血管疾患の有病率の上昇、製品開発における技術の進歩、老年人口や座りがちなライフスタイルの増加、心血管疾患に関する意識の高まりによって後押しされています。
心電図(ECG)モニタリング機器の市場力学
心電図(ECG)モニタリング機器は、心拍の知覚、心筋虚血や梗塞の診断、伝導系の欠陥、前駆動、QT延長症候群、心房異常、心膜炎、心室肥大などの疾患にとってもっとも重要な検査であるため、非常に有益であることが判明しました。
世界保健機関(WHO)(2021)が発表したデータによると、心血管系疾患(CVD)は全世界の主な死因であり、この疾患群は毎年推定1,790万人の命を奪っています。
CVDは、心臓と血管に特に影響を及ぼす疾患群として分類されます。CVDには、冠動脈性心疾患、リウマチ性心疾患、脳血管疾患などが含まれます。
さらに、WHO(2021)の同じデータでは、CVDによる死亡の5分の4超が脳卒中と心臓発作を主な原因としており、これらの死亡の3分の1は70歳未満で早期に発生すると述べられています。CVDによる死亡の4分の3超は中低所得国で起こっています。
European Society for Cardiology(2017)のデータによると、毎年欧州では心血管疾患(CVD)が390万人の死因となっており、欧州連合(EU)では180万人超が死亡しています。欧州における全死亡の約45%、EUでは37%を占めています。
さらに、ESCが2019年に発表した統計によると、ESC加盟国全体のCVDによる死亡者数は男女ともにがんによる死亡者数をはるかに上回り、男性110万人、女性88万7,688人が罹患していますが、一部の高所得国ではがんによる死亡者数がCVDによる死亡者数を上回っています。
加えて、WHO(2017)が発表した欧州のデータによると、CVDが原因として挙げられている死亡者数は、欧州において約46倍多いです。
上記の事実は、世界中で増加するCVDの疾病負担に対処するための対策が切実に必要であることを示しています。アテローム性動脈硬化症、不整脈などの適応症は患者のQOLに影響を与えます。さらに、多くの場合、心拍と活動を定期的にモニタリングすることによって、CVDの重症度を軽減することができます。これは、ECGモニタリング機器を展開することで実現できます。これらの機器により、医療従事者だけでなく患者も必要に応じて伝導系の不具合を診断できるようになり、疾病予後の改善だけでなく疾病の早期診断にも役立ちます。そのため、世界のECGモニタリング機器市場は予測期間に注目すべき成長を示す見込みです。
しかし、発展途上国では必要な医療インフラが整備されておらず、製品承認に対する規制プロセスが厳しいことが、ECGモニタリング機器市場の成長に対する一定の抑制要因になる可能性があります。
ECGモニタリング機器市場のセグメント分析
ECGモニタリング機器市場の製品セグメントでは、ホルターモニターセグメントが予測期間に最大の市場シェアを獲得する見込みです。ホルターモニターは、患者の異常な心臓機能を検出するためにもっとも一般的に使用されている機器です。また、診断や心臓の正常な機能の維持にも役立っています。これらの機器は一般的に病院内で使用され、患者のECGモニタリングの標準としてもっとも好まれる方式となっています。
さらに、これらは心臓に長時間接続されることから、技術の進歩により、心拍の不規則性をより正確に検出できるようになっています。Bluetoothセンサー技術やモバイルアプリ技術を搭載した商業上先進のホルターモニターの開発は、世界のECG市場の人気を促進すると予測されます。
当レポートでは、世界の心電図(ECG)モニタリング機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Electrocardiogram (ECG) Monitoring Equipment Market By Product (Resting ECG Systems, Stress ECG Systems, Holter Monitors, Cardiopulmonary Stress Testing System), By Type (Single Lead, 3-6 Lead, 12-Lead), By Modality Type (Portable, Stationary, Wearables), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising technological advancement and increasing prevalence of cardiovascular diseases
Global Electrocardiogram (ECG) Monitoring Equipment Market was valued at USD 4.44 billion in 2021, growing at a CAGR of 5.74% during the forecast period from 2024 to 2030, to reach USD 6.20 billion by 2030. The demand for Electrocardiogram (ECG) Monitoring Equipment is primarily being boosted by the rising prevalence of cardiovascular diseases, technological advancement in product development, increasing geriatric population, sedentary lifestyle, and increasing awareness regarding cardiovascular diseases.
Electrocardiogram (ECG) Monitoring Equipment Market Dynamics:
Electrocardiogram (ECG) Monitoring Equipment was found to be extremely beneficial as it is the most important test for heart rhythm perception, myocardial ischemia, and infarction diagnosis, defects of the conduction system, preexcitation, long QT syndromes, atrial abnormalities, pericarditis, ventricular hypertrophy, and other disorders.
As per the data provided by the World Health Organization 2021, cardiovascular diseases (CVDs) are the leading cause of death across the globe, wherein this group of disease-account for an estimated 17.9 million lives each year.
CVDs are classified as a group of disorders that specifically affect the heart and blood vessels. Some of the CVDs include coronary heart disease, rheumatic heart disease, cerebrovascular disease, and other conditions.
Furthermore, the same data by the WHO 2021 presented that over four out of five CVD deaths list strokes and heart attacks as the main cause, and one-third of these deaths are said to occur prematurely in people below 70 years of age. Over three-quarters of CVD deaths take place in low- and middle-income countries.
According to the data provided by the European Society for Cardiology (ESC) 2017 data, each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the EU.
Additionally, the statistics provided by the ESC for 2019 presented that CVD deaths across ESC member countries far exceeded the cancer deaths for both sexes, affecting 1.1 million males and 887,688 females, although cancer now causes more deaths than CVD in certain high-income countries.
Additionally, as per the data provided by the WHO 2017 data for Europe, deaths, where CVD is listed as a cause, are about 46 times higher in Europe.
The above-mentioned facts state the dire need for measures to address the rising disease burden of CVDs across the globe. Indications such as atherosclerosis, arrhythmias can affect the quality of life of patients. Furthermore, in many cases, the severity of CVDs can be reduced by regular monitoring of cardiac rhythms and activities. This can be achieved by deploying ECG Monitoring Equipment. These devices enable healthcare providers as well as patients to diagnose the defects of the conduction system as per the need, thereby helping in the improvement of disease prognosis as well helping in early disease diagnosis. Therefore, the Global ECG Monitoring Equipment market is expected to witness remarkable growth during the forecast period.
However, non-availability of the required healthcare infrastructure in developing economies, and stringent regulatory process for product approval may prove to be certain restraints to the ECG Monitoring Equipment market growth.
ECG Monitoring Equipment Market Segment Analysis:
ECG Monitoring Equipment by Product (Resting ECG Systems, Stress ECG Systems, Holter Monitors, Cardiopulmonary Stress Testing System), By Type (Single Lead, 3-6 Lead, 12-Lead), By Modality Type (Portable, Stationary, Wearables), By End User (Hospitals, Ambulatory Care, Others), and ECG Monitoring Equipment market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
ECG Monitoring Equipment market product segment, the Holter monitors segment is expected to amass the largest market share during the forecast period. Holter monitors have been the most commonly used device to detect abnormal heart functioning in patients. They also help in diagnosis and in maintaining the normal functioning of the heart. These devices are generally found in hospitals setups and have been the conventional and most preferred mode of ECG monitoring of patients.
In addition, technological advancements like more accurate detection of any irregularities in the heart's rhythm as it is connected to the heart for a much longer time. The development of commercially advanced Holter monitors, with enabled Bluetooth sensor technology and mobile app technology, is anticipated to drive the popularity of the Global ECG market.
Whereas in the modality type segment, the wearables segment is expected to show faster growth in the forecast period. This can be attributed to the technological advancements, making them accessible to a wider patient population.
Therefore, the constant technological advancements coupled with the extended application of ECG devices present a positive market outlook for the ECG devices among other product types.
North America is expected to dominate the Overall ECG Monitoring Equipment Market:
Among all the regions, North America is expected to account for the largest share in the ECG Monitoring Equipment market. The growing prevalence of cardiovascular diseases, access to better healthcare infrastructure, and growing awareness regarding cardiac diseases coupled with the presence of major ECG Monitoring Equipment market players in the region are predicted to be the major influencing factors in driving the overall growth of the ECG Monitoring Equipment market over the forecast period.
As per the facts provided by the Centers for Disease Prevention and Control (CDC) 2020, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States where about 655,000 Americans die from heart disease each year.
In addition to the above numbers, the data provided by the American Heart Association mentioned that chronic heart disease remains the leading cause of death in the US, according to 2018 data. The data sheet indicated that in 2018, CHD accounted for approximately 13% of deaths in the US causing 365,744 deaths.
The well-established healthcare infrastructure in the country with supportive reimbursement programs covering the costs for the implantable devices as well as the procedure further encourage people to opt for such devices.
In July 2021, EchoNous, the leader in ultra-portable, AI-guided point-of-care ultrasound (POCUS) tools and software, announced that the company has partnered with Singapore-based Us2.ai, developers of machine learning-driven software that automates the analyses of echocardiographic imagery and measurements.
Considering the presence of a large patient pool in the US coupled with new product launches, the market for ECG Monitoring Equipment looks promising in the United States.
ECG Monitoring Equipment Market Key Players:
Some of the key market players operating in the ECG Monitoring Equipment market include General Electric Company (GE Healthcare), Schiller AG, Koninklijke Philips N.V., Nihon Kohden Corporation, Customed GmbH, CORTEX Biophysik GmbH, Welch Allyn®, Norav Medical, Neurosoft, ACS Diagnostics, Medtronic, Microport Scientific Corporation, LUMED srl Sede legale, iRhythm Technologies, Inc., and others.
Recent Developmental Activities in ECG Monitoring Equipment Market:
In August 2021, Leading smart home medical devices brand Wellue officially announced the launch of its ECG Recorder with AI Analysis.
In July 2021, AliveCor's electrocardiogram (ECG) device, KardiaMobile 6L received the 510(k) clearance from the US Food and Drug Administration (FDA). KardiaMobile 6L is the first-ever handheld ECG device to receive FDA approval for QTc measurement in patients.
In July 2021, Two artificial intelligence (AI) algorithms designed to diagnose people with heart rhythm abnormalities have been approved by the FDA for use with Medtronic's LINQ II cardiac monitor. The AccuRhythm algorithms will be released later this year for use by all implanted LINQ II devices in the US.
Key Takeaways from the ECG Monitoring Equipment Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ECG Monitoring Equipment market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global ECG Monitoring Equipment Market.
Various opportunities are available for the other competitor in the ECG Monitoring Equipment Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for ECG Monitoring Equipment market growth in the coming future?
Target Audience who can be benefited from this ECG Monitoring Equipment Market Ket Report Study
ECG Monitoring Equipment providers
Research organizations and consulting companies
ECG Monitoring Equipment related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in ECG Monitoring Equipment
Various End-users want to know more about the ECG Monitoring Equipment Market and the latest technological developments in the ECG Monitoring Equipment market.
Frequently Asked Questions for ECG Monitoring Equipment Market:
An electrocardiogram (ECG or EKG) records an electrical pulse from the heart. It is the most important test for heart rhythm perception, myocardial ischemia and infarction diagnosis, defects of the conduction system, preexcitation, long QT syndromes, atrial abnormalities, pericarditis, ventricular hypertrophy, and other disorders.
Global Electrocardiogram (ECG) Monitoring Equipment Market was valued at USD 4.44 billion in 2021, growing at a CAGR of 5.74% during the forecast period from 2024 to 2030, to reach USD 6.20 billion by 2030.
The major drivers driving the demand for ECG Monitoring Equipment are the rising prevalence of cardiovascular diseases, technological advancement in product development, increasing geriatric population, sedentary lifestyle, and increasing awareness regarding cardiovascular diseases.
Some of the key market players operating in the ECG Monitoring Equipment market include General Electric Company (GE Healthcare), Schiller AG, Koninklijke Philips N.V., Nihon Kohden Corporation, Customed GmbH, CORTEX Biophysik GmbH, Welch Allyn®, Norav Medical, Neurosoft, ACS Diagnostics, Medtronic, Microport Scientific Corporation, LUMED srl Sede legale, iRhythm Technologies, Inc., and others.
North America is expected to dominate the overall ECG Monitoring Equipment market during the forecast period, 2024 to 2030. This domination is due to the growing prevalence of cardiovascular diseases, access to better healthcare infrastructure, and growing awareness regarding cardiac diseases coupled with the presence of major market players in the region.